Aamir Malik, Pfizer chief business innovation officer
Albert Bourla picks a new dealmaker to lead the hunt for more drugs to swell Pfizer’s pipeline
A new dealmaker is joining the executive crew at Pfizer.
The pharma giant says that McKinsey vet Aamir Malik is jumping on board as a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
